SUN PHARMA – Walk-In Interviews for R&D / Process Development (API) on 14th May’ 2022


Sun Pharmaceutical Industries Limited is the largest specialty generic pharmaceutical company in the world. We provide high quality, affordable medicine trusted by healthcare professionals and patients in over 150 countries. It is also India’s largest, most trusted and most valuable pharmaceutical company by market capitalization. To keep pace with our growth plan we require young and energetic professionals of our API plant at Panoli.

 

Sun Pharmaceutical Industries Ltd Panoli
Walk in Interview on 14th May 2022.

  1. Sr. Officer & Officer – R&D / Process Development (API): Candidates having educational qualification of M.Sc with experience of 2 to 6 Years.
  2. Sr. Officer & Executive – Production (API): Candidates having educational qualification of B.E Chemical / M.E Chemical / B.Tech / M.Tech with Specialization with experience of 4 to 6 Years.

 

Note:

  1. For all the above mentioned positions, Candidates Should have experience in regulated plants like USFDA, EU GMP, WHO GMP.
  2. Interested candidates should carry their updated resume along with photograph, Salary Supporting with components breakup (Latest Increment Letter / Revised Salary Letter / Appointment Letter).

 

DETAILS OF WALK-IN INTERVIEW:

Date: 14th May, 2022

Time: 10:00AM to 3:00PM

Venue: Sun Pharmaceutical Industries Ltd Panoli

Plot No – 24/2 & 25 Phase IV, GIDC Industrial Estate, Panoli – 394116, Dist. Bharuch

Note– Sun Pharma does not seek payment of any kind from a prospective candidates for employment with Sun Pharma or authorize any agency or any individual to collect or charge any fees or charges for recruitment. Please be cautious while dealing with any recruitment agency or anyone asking you to pay money representing himself to be representing Sun Pharma.

 

SUN PHARMA - Walk-In Interviews for R&D / Process Development (API) on 14th May' 2022 AndhraShakthi - Pharmacy Jobs

 

More Job Updates Join What’s App Group – Click Here

Join Telegram Group – Click Here

 

Leave a Comment

x